Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis

A. J. Ruiz Reina, M. Gonzalez, E. Vazquez, R. I. Aguilar Perez Grovas, I. Vazquez Rico, T. Garcia Barrera, J. Gravalos Guzman, J. L. Sanchez Ramos, J. A. Maldonado Perez, J. L. Gomez Ariza, A. Pereira Vega (Huelva, Spain)

Source: International Congress 2014 – Biology and pathology of thoracic tumours
Session: Biology and pathology of thoracic tumours
Session type: Thematic Poster Session
Number: 2694

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. J. Ruiz Reina, M. Gonzalez, E. Vazquez, R. I. Aguilar Perez Grovas, I. Vazquez Rico, T. Garcia Barrera, J. Gravalos Guzman, J. L. Sanchez Ramos, J. A. Maldonado Perez, J. L. Gomez Ariza, A. Pereira Vega (Huelva, Spain). Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis. Eur Respir J 2014; 44: Suppl. 58, 2694

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Relationship between risk factors for lung cancer and tumor size
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Symptom-to-treatment intervals in lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


The value of miR221 and miR222 as a biomarker in non small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Association between leptin and risk of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Functional impairment of NK cells in non-small-cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Comorbitities, responses and survival in pts with NSCLC
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Accelerated lung function decline increases the risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

The research on early detection of lung cancer with exhaled volatile organic compounds
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Exhaled breath temperature in NSCLC: Could be a new non invasive marker?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



Radiation pneumonitis; early diagnosis and associated factors
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014